Single Dose Study of PF-06815345 in Healthy Subjects
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The current study is the first clinical trial proposed with PF-06815345. It is designed to
evaluate the safety, tolerability, and pharmacokinetics (PK) following administration of
single oral doses of PF-06815345 to healthy adult subjects.